JP3224419B2 - 生体試料中の蛋白質指示薬としてのメロシアニン及びニトロ又はニトロソ置換ポリハロゲン化フェノールスルホンフタレイン - Google Patents

生体試料中の蛋白質指示薬としてのメロシアニン及びニトロ又はニトロソ置換ポリハロゲン化フェノールスルホンフタレイン

Info

Publication number
JP3224419B2
JP3224419B2 JP16997392A JP16997392A JP3224419B2 JP 3224419 B2 JP3224419 B2 JP 3224419B2 JP 16997392 A JP16997392 A JP 16997392A JP 16997392 A JP16997392 A JP 16997392A JP 3224419 B2 JP3224419 B2 JP 3224419B2
Authority
JP
Japan
Prior art keywords
atom
protein
bromine
error indicator
iodine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP16997392A
Other languages
English (en)
Japanese (ja)
Other versions
JPH05232119A (ja
Inventor
ポール・エフ・コーリー
アンジェラ・エー・マイケルズ
ロナルド・ジー・ソマー
Original Assignee
バイエルコーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイエルコーポレーション filed Critical バイエルコーポレーション
Publication of JPH05232119A publication Critical patent/JPH05232119A/ja
Application granted granted Critical
Publication of JP3224419B2 publication Critical patent/JP3224419B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/6839—Total protein determination, e.g. albumin in urine involving dyes, e.g. Coomassie blue, bromcresol green
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
JP16997392A 1991-06-06 1992-06-05 生体試料中の蛋白質指示薬としてのメロシアニン及びニトロ又はニトロソ置換ポリハロゲン化フェノールスルホンフタレイン Expired - Fee Related JP3224419B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71095391A 1991-06-06 1991-06-06
US710953 1991-06-06

Publications (2)

Publication Number Publication Date
JPH05232119A JPH05232119A (ja) 1993-09-07
JP3224419B2 true JP3224419B2 (ja) 2001-10-29

Family

ID=24856188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16997392A Expired - Fee Related JP3224419B2 (ja) 1991-06-06 1992-06-05 生体試料中の蛋白質指示薬としてのメロシアニン及びニトロ又はニトロソ置換ポリハロゲン化フェノールスルホンフタレイン

Country Status (12)

Country Link
US (1) US5279790A (US07563621-20090721-C00007.png)
EP (1) EP0517050B1 (US07563621-20090721-C00007.png)
JP (1) JP3224419B2 (US07563621-20090721-C00007.png)
KR (1) KR100231078B1 (US07563621-20090721-C00007.png)
AT (1) ATE143144T1 (US07563621-20090721-C00007.png)
AU (1) AU637017B2 (US07563621-20090721-C00007.png)
CA (1) CA2070040A1 (US07563621-20090721-C00007.png)
DE (1) DE69213826T2 (US07563621-20090721-C00007.png)
DK (1) DK0517050T3 (US07563621-20090721-C00007.png)
ES (1) ES2092595T3 (US07563621-20090721-C00007.png)
GR (1) GR3021150T3 (US07563621-20090721-C00007.png)
TW (1) TW227043B (US07563621-20090721-C00007.png)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326707A (en) * 1991-11-29 1994-07-05 Miles Inc. Composition and device for urinary protein assay and method of using the same
US5424215A (en) * 1994-02-07 1995-06-13 Miles Inc. Assay for the determination of protein in a biological sample
US5593895A (en) * 1995-04-27 1997-01-14 Bayer Corporation Method for the detection of protein in urine
US5616502A (en) * 1995-05-19 1997-04-01 Molecular Probes, Inc. Non-specific protein staining using merocyanine dyes
US5716851A (en) * 1996-01-16 1998-02-10 Bayer Corporation Glass/cellulose as protein reagent
US5753455A (en) * 1996-09-03 1998-05-19 Bayer Corporation Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid
US5908787A (en) * 1997-09-23 1999-06-01 Bayer Corporation Total protein detection method
WO2003001213A2 (en) * 2001-06-25 2003-01-03 Bayer Healthcare Llc Total protein detection methods and devices at low ph
US7459127B2 (en) * 2002-02-26 2008-12-02 Siemens Healthcare Diagnostics Inc. Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
AU2003206034A1 (en) * 2002-03-05 2003-09-16 Bayer Healthcare Llc Absorbing organic reagent into diagnostic test devices by formation of amine salt complexes
US7094354B2 (en) * 2002-12-19 2006-08-22 Bayer Healthcare Llc Method and apparatus for separation of particles in a microfluidic device
US7125711B2 (en) * 2002-12-19 2006-10-24 Bayer Healthcare Llc Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
US7435381B2 (en) * 2003-05-29 2008-10-14 Siemens Healthcare Diagnostics Inc. Packaging of microfluidic devices
US20040265172A1 (en) * 2003-06-27 2004-12-30 Pugia Michael J. Method and apparatus for entry and storage of specimens into a microfluidic device
US20040265171A1 (en) * 2003-06-27 2004-12-30 Pugia Michael J. Method for uniform application of fluid into a reactive reagent area
US20080257754A1 (en) * 2003-06-27 2008-10-23 Pugia Michael J Method and apparatus for entry of specimens into a microfluidic device
US7347617B2 (en) * 2003-08-19 2008-03-25 Siemens Healthcare Diagnostics Inc. Mixing in microfluidic devices
DE10346863A1 (de) * 2003-10-09 2005-05-04 Roche Diagnostics Gmbh On-Board-Kontrolle für Analyseelemente
US7776529B2 (en) 2003-12-05 2010-08-17 Life Technologies Corporation Methine-substituted cyanine dye compounds
US7282349B2 (en) 2003-12-16 2007-10-16 Kimberly-Clark Worldwide, Inc. Solvatochromatic bacterial detection
US7399608B2 (en) 2003-12-16 2008-07-15 Kimberly-Clark Worldwide, Inc. Microbial detection and quantification
US7300770B2 (en) 2004-12-16 2007-11-27 Kimberly-Clark Worldwide, Inc. Detection of microbe contamination on elastomeric articles
US20060084175A1 (en) * 2004-10-19 2006-04-20 Wayne Comper Colorimetric strip containing coomassie blue for semi-quantitation of albumin
US7598390B2 (en) 2005-05-11 2009-10-06 Life Technologies Corporation Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
US9125973B2 (en) 2007-07-20 2015-09-08 Baxter International Inc. Antimicrobial housing and cover for a medical device
USRE47452E1 (en) 2007-07-20 2019-06-25 Baxter International Inc. Antimicrobial housing and cover for a medical device
CN102964863B (zh) * 2010-04-10 2014-04-16 大连理工大学 吲哚类半菁染料的合成与应用
CN101805526A (zh) * 2010-04-10 2010-08-18 大连理工大学 吲哚类半菁染料的合成与应用
US9933359B2 (en) * 2014-06-23 2018-04-03 Xerox Corporation Vendor exclusivity security feature for paper-based diagnostic solution
CN106349146A (zh) * 2016-08-11 2017-01-25 潘忠宁 一种新型光致变色材料的合成方法
CN106957247B (zh) * 2017-03-16 2020-03-20 长春万成生物电子工程有限公司 一种微蛋白指示剂的纯化方法
CN111004166A (zh) * 2019-12-27 2020-04-14 苏州络森生物科技有限公司 一种spdib的制备方法
CN116715977A (zh) * 2023-06-12 2023-09-08 沈阳师范大学 一种半菁染料的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2510633C3 (de) * 1975-03-12 1978-07-13 Boehringer Mannheim Gmbh, 6800 Mannheim Diagnostisches Mittel zum Nachweis von Eiweiß in Körperflüssigkeiten und dafür geeignete Indikatorfarbstoffe
JPS5767860A (en) * 1980-10-15 1982-04-24 Fuji Photo Film Co Ltd Material for multilayer analysis
US5049358A (en) * 1988-09-30 1991-09-17 Miles Inc. Composition and test device for assaying for proteins
US5122602A (en) * 1989-02-13 1992-06-16 Miles Inc. Chromogenic merocyanine enzyme substrates
US5264589A (en) * 1991-06-06 1993-11-23 Miles Inc. Merocyanine protein error indicators

Also Published As

Publication number Publication date
DE69213826D1 (de) 1996-10-24
EP0517050A2 (en) 1992-12-09
KR930000953A (ko) 1993-01-16
AU637017B2 (en) 1993-05-13
ATE143144T1 (de) 1996-10-15
GR3021150T3 (en) 1996-12-31
CA2070040A1 (en) 1992-12-07
KR100231078B1 (ko) 1999-11-15
AU1721092A (en) 1992-12-17
JPH05232119A (ja) 1993-09-07
EP0517050B1 (en) 1996-09-18
US5279790A (en) 1994-01-18
DK0517050T3 (US07563621-20090721-C00007.png) 1997-03-03
ES2092595T3 (es) 1996-12-01
EP0517050A3 (en) 1993-03-03
DE69213826T2 (de) 1997-01-30
TW227043B (US07563621-20090721-C00007.png) 1994-07-21

Similar Documents

Publication Publication Date Title
JP3224419B2 (ja) 生体試料中の蛋白質指示薬としてのメロシアニン及びニトロ又はニトロソ置換ポリハロゲン化フェノールスルホンフタレイン
JP3153831B2 (ja) メロシアニンタンパク質誤差指示薬
JP3157607B2 (ja) 生体試料中の蛋白質指示薬としてのニトロ又はニトロソ置換ポリハロゲン化フェノールスルホンフタレイン
JP4472795B2 (ja) 蛍光イオノホア化合物
JP6177931B2 (ja) 選択的にマグネシウムイオンを決定するための多層デバイス
JPH10338695A (ja) インダセン誘導体
CA1258672A (en) Calcium complexing dyes and their use in analytical compositions, elements and methods
US3880588A (en) Diagnostic agent for detecting bilirubin
JPS6142749B2 (US07563621-20090721-C00007.png)
EP0476457A2 (en) 2-Benzothiazolyl tetrazolium salt indicators
CN112876426B (zh) 检测人血清白蛋白的苯并噻唑类荧光探针及制备和试剂盒
CN118290413B (zh) 用于人血清白蛋白检测的近红外荧光探针及其制备方法与应用
KR100235367B1 (ko) 메로시아닌 단백오차 지시제를 함유하는 시험 스트립을 사용한 단백질 검출방법
EP0476455B1 (en) Phenyl-substituted 2-thiazolyl tetrazolium salt indicators
EP0248112A2 (en) Use of thiophenes as pH indicators, in particular in a non-enzymatic glucose test
JP2001133407A (ja) 陰イオン濃度の測定方法

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees